Ingalls & Snyder LLC Corcept Therapeutics Inc Transaction History

Ingalls & Snyder LLC

  • $2.56 Billion
  • Q3 2024

A detailed history of Ingalls & Snyder LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Ingalls & Snyder LLC holds 11,500 shares of CORT stock, worth $661,710. This represents 0.02% of its overall portfolio holdings.

Number of Shares
11,500
Previous 8,000 43.75%
Holding current value
$661,710
Previous $260,000 104.62%
% of portfolio
0.02%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$29.51 - $46.26 $845,461 - $1.33 Million
28,650 Added 0.35%
8,266,756 $383 Million
Q2 2024

Jul 31, 2024
SELL
$22.21 - $34.48 $1.44 Million - $2.24 Million
-65,041 Reduced 0.78%
8,238,106 $268 Million
Q1 2024

May 13, 2024
SELL
$21.1 - $27.46 $1.03 Million - $1.34 Million
-48,680 Reduced 0.58%
8,303,147 $209 Million
Q4 2023

Jan 29, 2024
BUY
$24.82 - $32.88 $288,755 - $382,525
11,634 Added 0.14%
8,351,827 $271 Million
Q3 2023

Nov 02, 2023
SELL
$21.97 - $33.8 $445,815 - $685,869
-20,292 Reduced 0.24%
8,340,193 $227 Million
Q2 2023

Jul 27, 2023
SELL
$21.44 - $25.15 $204,366 - $239,729
-9,532 Reduced 0.11%
8,360,485 $186 Million
Q1 2023

May 09, 2023
BUY
$19.2 - $24.47 $29.7 Million - $37.8 Million
1,544,755 Added 22.63%
8,370,017 $181 Million
Q4 2022

Jan 31, 2023
SELL
$19.95 - $29.96 $2.51 Million - $3.77 Million
-125,815 Reduced 1.81%
6,825,262 $139 Million
Q3 2022

Oct 21, 2022
SELL
$24.7 - $29.12 $1.02 Million - $1.2 Million
-41,171 Reduced 0.59%
6,951,077 $178 Million
Q2 2022

Aug 11, 2022
BUY
$17.33 - $25.3 $1.4 Million - $2.05 Million
80,872 Added 1.17%
6,992,248 $166 Million
Q1 2022

May 09, 2022
BUY
$16.53 - $25.21 $2.87 Million - $4.37 Million
173,478 Added 2.57%
6,911,376 $156 Million
Q4 2021

Feb 11, 2022
SELL
$17.1 - $23.34 $5.39 Million - $7.36 Million
-315,472 Reduced 4.47%
6,737,898 $133 Million
Q3 2021

Oct 27, 2021
SELL
$19.68 - $22.53 $350,008 - $400,696
-17,785 Reduced 0.25%
7,053,370 $139 Million
Q2 2021

Aug 03, 2021
BUY
$19.97 - $24.43 $2.48 Million - $3.04 Million
124,423 Added 1.79%
7,071,155 $156 Million
Q1 2021

Apr 21, 2021
SELL
$23.49 - $30.56 $8.35 Million - $10.9 Million
-355,586 Reduced 4.87%
6,946,732 $165 Million
Q4 2020

Jan 27, 2021
SELL
$16.78 - $27.3 $3.18 Million - $5.17 Million
-189,435 Reduced 2.53%
7,302,318 $191 Million
Q3 2020

Oct 21, 2020
SELL
$12.46 - $19.98 $1.34 Million - $2.15 Million
-107,536 Reduced 1.42%
7,491,753 $130 Million
Q2 2020

Jul 31, 2020
SELL
$11.0 - $18.26 $4.45 Million - $7.38 Million
-404,434 Reduced 5.05%
7,599,289 $128 Million
Q1 2020

Apr 22, 2020
SELL
$10.11 - $14.04 $107,449 - $149,217
-10,628 Reduced 0.13%
8,003,723 $95.2 Million
Q4 2019

Jan 15, 2020
SELL
$12.06 - $16.96 $8.42 Million - $11.8 Million
-697,825 Reduced 8.01%
8,014,351 $97 Million
Q3 2019

Oct 16, 2019
BUY
$10.41 - $14.66 $1.98 Million - $2.79 Million
190,377 Added 2.23%
8,712,176 $123 Million
Q2 2019

Jul 11, 2019
BUY
$9.78 - $12.76 $1.47 Million - $1.91 Million
149,798 Added 1.79%
8,521,799 $95 Million
Q1 2019

Apr 11, 2019
SELL
$10.03 - $15.71 $18,936 - $29,660
-1,888 Reduced 0.02%
8,372,001 $98.3 Million
Q4 2018

Jan 24, 2019
SELL
$11.29 - $17.19 $275,148 - $418,937
-24,371 Reduced 0.29%
8,373,889 $112 Million
Q3 2018

Oct 24, 2018
BUY
$12.27 - $15.65 $13.3 Million - $16.9 Million
1,081,270 Added 14.78%
8,398,260 $118 Million
Q2 2018

Aug 10, 2018
BUY
$15.3 - $19.69 $7.64 Million - $9.83 Million
499,450 Added 7.33%
7,316,990 $115 Million
Q1 2018

Apr 17, 2018
SELL
$14.59 - $25.5 $1.55 Million - $2.71 Million
-106,155 Reduced 1.53%
6,817,540 $112 Million
Q4 2017

Jan 19, 2018
BUY
$15.77 - $20.72 $703,294 - $924,049
44,597 Added 0.65%
6,923,695 $125 Million
Q3 2017

Oct 20, 2017
BUY
$12.3 - $19.3 $84.6 Million - $133 Million
6,879,098
6,879,098 $133 Million

Others Institutions Holding CORT

# of Institutions
347
Shares Held
86.6M
Call Options Held
1.12M
Put Options Held
667K
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.16B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Ingalls & Snyder LLC Portfolio

Follow Ingalls & Snyder LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ingalls & Snyder LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email